Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and is associated with an increased risk of stroke, heart failure (HF) and mortality [1]. In this regard, the CHA2DS2-VASc score is a well-known predictor of stroke in patients with AF, with some studies evaluating its use as a marker for predicting all-cause death [2,3]. Cardiac troponin I (cTnI) has consistently provided prognostic information on the risk of stroke, vascular events and mortality in patients with AF [4].